Underwriters exercise over-allotment option in Uroplasty's common stock public offering

Uroplasty, Inc. (Nasdaq: UPI) announced today that the underwriters for the recently announced public offering of Uroplasty common stock have exercised in full their over-allotment option to purchase an additional 600,000 shares of the Company's common stock.  The 4,600,000 shares of Uroplasty common stock in the offering, including the 600,000 shares subject to the over-allotment option, are being sold at a price to the public of $3.50 per share.

All of the shares in the offering are being offered by Uroplasty.  The offering, including the offering of the over-allotment shares, is expected to close on July 27, 2010.  Oppenheimer & Co. Inc. is the sole book-running manager for the offering and JMP Securities LLC is acting as co-manager for the offering.